MSD Animal Health THERE S ONLY ONE THING THAT DRIVES US. Updated Brand Video The Science of Healthier Animals TM

Similar documents
M. hyo. M. hyo. M. hyo. Single injection. Double protection. Ready-to-use protection against both PCV2 and M. hyo. It s easy. It works.

Intradermal and Needle free A perfect match*

The FIRST intradermal M Hyo vaccine

ALL YOU NEED FOR A NEEDLE-FREE INTRADERMAL FUTURE USE THE MENU BUTTONS TO NAVIGATE THROUGH THE DOCUMENT

A guide to Pfizer. products

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

CUSTOMIZED CONTROL. Because every herd is unique

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Healthy Animals. Figure One Healthy Animals

The PRRS vaccine for the entire herd. H appy to. be healthy. Licensed. in breeding pigs and piglets. from weeks of age

Herd Health for Small-Scale Swine Farms Ines Rodriguez, M.S., V.M.D.

PCV2 and Mycoplasma Vaccine Comparison in a Midwest Commercial Swine Herd

The NEXT GENERATION Circumvent G2 gives you even more PCV2 OPTIONS! THE NEXT GENERATION THE SCIENCE OF HEALTHIER ANIMALS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

THE NEXT GENERATION CIRCUMVENT G2 GIVES YOU EVEN MORE PCV2 OPTIONS!

Patrick L. Graham, DVM, MS

Fostera PCV MH: Efficacy of Single-Dose Vaccination in Swine Subsequently Challenged with PCV2 and/or Mycoplasma hyopneu moniae

Normal lung Virus infection. Mycoplasma hyopneumoniae Actinobacillus pleuropneumoniae Not always easy. Årsmøde Vet-Team

Martelli et al. BMC Veterinary Research (2016) 12:77 DOI /s

Porcilis PRRS and Porcilis M Hyo

Introduction: Goals and expectations of vaccination programs in swine intended for show purposes

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Experiences with Ingelvac MycoFLEX Vaccine and FLEXcombo in Australia

PRRS Control Practitioner s View. John Hayden BVSc MRCVS Integra Veterinary Services

Detection of respiratory pathogens in oral fluid; sampling recommendations in commercial conditions.

Material and methods. Challenge The pigs were challenged at 16 weeks of age when the challenge control pigs became antibody negative by the

Technical Bulletin. Pfizer Animal Health. RespiSure-ONE for one-day-of-age vaccination: Assessing vaccine efficacy RSP Key Points.

Request for Diagnostic Testing Pig / Swine

THE DANISH SPF SYSTEM & DIFFERENT DISEASE ELIMINATION PROCEDURES

Locke Karriker, 2008 Iowa Pork Regional Conferences 1

! "# $% % &! % % ' ( #! )*!%( #!$! ' # %!% #&! #! %$ # # %%!! +! & # #$ % $ % ,-#%.#!$ #$ &#"/ #! %0 ' ! $!$ $" "!&#! 0 &!&,%. % !

Application of diagnostic tools for better monitoring and control of respiratory disease

PCVAD A PRODUCER S GUIDE TO MANAGING. Porcine Circovirus Associated Diseases

Veterinary Microbiology

Institute for State Control of Veterinary Biologicals and Medicines Ústav pro státní kontrolu veterinárních biopreparátů a léčiv

Ingelvac CircoFLEX Symposium

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Request for Diagnostic Testing Pig / Swine

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/17

FLEX Symposium & PCVAD Research Award Winners Presentation

Rotavec Corona Emulsion for injection for cattle. Introduction. Company name: MSD Animal Health. Address: Walton Manor. Walton. Milton Keynes MK7 7AJ

GROW/FINISH VARIATION: COST AND CONTROL STRATEGIES

Abstract. Introduction

Evaluation of welfare aspects in suckling piglets after intradermal vaccine application with the IDAL injector

PEDV in the US: Overview, history and lessons

Porcilis Ery+Parvo+Lepto

Sponsors. Production Assistant Janice Storebo. Formatting Tina Smith. CD-ROM David Brown

EVALUATION OF A PCV2 VACCINE ON FINISHING PIG GROWTH PERFORMANCE AND MORTALITY RATE 1

FMD VACCINE AND VACCINATION. Ahmad Al-Majali Dean, Faculty of Vet Medicine JUST Jordan

FORGOTTEN DISEASES. Bob Friendship Department of Population Medicine University of Guelph Guelph, Ontario N1G 2W1

Gripovac 3 is an inactivated, adjuvanted vaccine intended for active immunisation of pigs against disease caused by Swine Influenza Virus.

SCIENTIFIC DISCUSSION

Responsible use of vaccines and vaccination in pig production

SUMMARY OF PRODUCT CHARACTERISTICS

Ho To, Nobuyuki Tsutsumi, Akihiro Tazumi, Takashi Kamada, Tetsuji Nagano, Shinya Nagai, Akira Iwata, Tetsuo Nunoya

Classical swine fever (CSF) - also known as hog cholera, is a highly contagious multisystemic, haemorrhagic, viral disease of swine.

Health Products Regulatory Authority

S.P.E.S. (Slaughterhouse Pleurisy Evaluation System) Proposal for a new inspective approach for pleurisy detection at slaughterhouse.

Diagnostic Center for Population and Animal Health

Assessment of neutralizing and non-neutralizing antibody responses against Porcine circovirus 2 in vaccinated and non-vaccinated farmed pigs

In this session you will learn:

Credits. Immunity in the Neonate. Neonatal Immunology All food animals are immunocompetent at birth. Colostral Anti-inflammatory Cytokines

Starting with Healthy Pigs E /06

Health Protection Concepts. Health Protection Concepts. Health Protection Concepts. Health Protection Concepts. Health Protection Concepts

Leptospirosis has changed. Here's how to meet the new threat

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Now with even more combinations, it s easier to find the best match for your operation.

A Review on the Impact of Mycoplasma hyopneumoniae Vaccination on Average Daily Gain in Swine

FIELD STUDY. Comparison of techniques for controlling the spread of PRRSV in a large swine herd. Summary. Materials and methods.

Evaluación económica de programas de control vs erradicación de enfermedades porcinas.

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

3. Antibody to PPRS Virus (PRRSV) 4. Antibody to Pseudorabies Virus /gpl Aujeszky s Disease (PRV/ADV gpl) 5. Antibody to Swine Salmonella

Technical Bulletin. Pfizer Animal Health. Comparative study demonstrates RespiSure

Regional PRRS eradication. Anders Elvstroem, DVM Svinepraksis.dk

ZOETIS ARE PROUD TO SUPPORT THE JOINT ACTION AGAINST BLUETONGUE CAMPAIGN

Effects of Porcine Circovirus Type 2 and Mycoplasma hyopneumoniae Vaccines on Nursery Pig Performance

Swine Reproductive Problems: Infectious Causes

Asst. Prof. Dusit Laohasinnarong, D.V.M., Grad. Dip. (IT), Ph.D. Department of Clinical Sciences and Public Health, Faculty of Veterinary Science

Novel Vaccine Delivery Technology

A two-year follow-up study of the PCV2 status of a Danish pig herd that was initially assumed to be PCV2-free

Suvaxyn Aujeszky 783+O/W

PRRS The Challenge Continues. Cameron Schmitt, DVM, MS Iowa Pork Congress

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Economic Impact of Disease

HOW DO I GET IT RIGHT? POST WEANING DISEASE CONTROL A UK PERSPECTIVE

SWINE HEALTH INFORMATION CENTER FINAL RESEARCH GRANT REPORT FORMAT

Porcine Reproductive and Respiratory Syndrome Virus

Paul-Ehrlich-Institut DE/V/0022/001/II/023/G Page 1

Health Interventions in Light of New Antibiotic Regulations Chris Rademacher, DVM

Sponsors. Production Assistant Janice Storebo. Formatting Tina Smith. CD-ROM David Brown

FIREWALL. The trivalent flu protection

PART 1 B SUMMARY OF PRODUCT CHARACTERISTICS, LABELLING AND PACKAGE LEAFLET

Biosecurity is many things:

Swine Biosecurity Practices

MINNESOTA VOLUNTARY PRRS ELIMINATION PROJECT. Pork Lenders Meeting July 29, 2011 Dave Wright, D.V.M.

Health Products Regulatory Authority

Transcription:

MSD Animal Health THERE S ONLY ONE THING THAT DRIVES US Updated Brand Video The Science of Healthier Animals TM

MSD Animal Health Breeding Herd and Progeny Vaccination Now and the Future APV Conference 10 th 12 th September 2017 Chris Brennan Technical Advisor - Swine

Purpose of Vaccination Prevent or minimise disease in the animal vaccinated Individual effect whereby antigens create immune response leading to production of memory T & B cells, and plasma cells Prevent animals from spreading disease Herd immunity increases Outbreaks less often and less severe 3

The AusVac Lab 1987 4

Bendigo Site Now 5

Swine Vaccine Range 6

Breeding Herd Vaccines ECOvac Polyvalent, killed whole cell vaccine containing E.coli serotypes including fimbrial antigens, K88, K99 and 987P involved in neonatal scours. 2 ml dose ECOvacLE Inactivated, adjuvanted vaccine comprised of E.coli, Erysipelothrix rhusiopathiae and Leptospira interrogans serovar pomona 4 ml dose PLEvac Inactivated, adjuvanted vaccine comprised of Porcine parvovirus, Erysipelothrix rhusiopathiae and Leptospira interrogans serovar pomona 4 ml dose 7

Vaccination Strategies TIMING VACCINE SELECTION 4 WEEKS AFTER SELECTION 7 WEEKS BEFORE FARROWING 3 WEEKS BEFORE FARROWING WEANING SOWS AND GILTS GILTS GILTS GILTS SOWS AND GILTS SOWS AND GILTS PLEvac ECOvac OUTDOOR SOWS AND GILTS PLEvac ALTERNATE PROGRAM ECOvacLE The use pattern in the above table is as per the registered label Product labels should always be consulted for full details for vaccine dosage and administration, prior to administration of any vaccine 8

M + PAC 9

M + PAC M + PAC Mycoplasma hyopneumoniae Inactivated Vaccine for Pigs Indication For the vaccination of healthy pigs as an aid in the prevention of pneumonia caused by Mycoplasma hyopneumoniae infection Vaccination Schedule 1 dose regime - 2 ml IM from 21 days of age 2 dose regime - 1 ml SC or IM from 7 days of age, repeated after 14 days Administration Injected intramuscularly, straight from the fridge Vaccine Storage Store between 2 C and 8 C (Refrigerate. Do not Freeze.) Protect from light. 10

Porcilis APPvac 11

Porcilis APPvac 12

Porcilis APPvac Whole cell Actinobacillus pleuropneumoniae vaccine containing: whole cells of APP serovars 1, 7 and 15 immune stimulating levels of Apx toxoids I, II and III outer membrane proteins double adjuvant system to increase immune stimulation Vaccinate pigs with 2 ml Porcilis APPvac around 8 weeks of age and again 2-3 weeks later 13

Porcilis PCV 14

Porcilis PCV For active immunisation of pigs to reduce the virus load in blood and lymphoid tissues and to reduce mortality and weight loss associated with Porcine Circovirus type 2 related infection (PCVD) occurring during the fattening period. Onset of immunity: 2 weeks Duration of immunity: 22 weeks In the case of low to medium levels of maternally derived antibodies against PCV-2 a single vaccination (2 ml) to pigs from 3 weeks of age. 15

Impact of Porcilis PCV on Viremia qpcr is: Predictive of clinical outcome Associated with lesions Indicates disease severity PCV2 DNA copies RESULT <10 6 POSITIVE SUBCLINICAL PCVD (?) >10 6 POSITIVE PCVD SUSPECT qpcr detects accurate amounts of viral genetic material in target tissues Martelli et al. Vet Microbiol 2011 10 7 POSITIVE PCVD 10 7 PCV2 genomic copies/ml of serum correlates with severe PCVD, lesions and poor prognosis 16

Impact of Porcilis PCV on Viremia cont. Paolo Martelli, Luca Ferrari, Marina Morganti, Elena De Angelis, Paolo Bonilauri, Stefano Guazzetti, Antonio Caleffi and Paolo Borghetti. One dose of a porcine circovirus 2 subunit vaccine induces humoral and cell-mediated immunity and protects against porcine circovirus-associated disease under field conditions. Veterinary Microbiology 149 (2011) 339-351. 17

Effects of Viremia Long duration of viremia = higher PCV2 load Has negative impact on growing pigs Viremia redirects energy and feed to the immune system and maintenance Pigs eat more and gain less Increases cost of production Viremia control with Porcilis PCV helps prevent PCVAD development 18

Vaccination Technique 1. Before using the vaccine, allow it to reach room temperature (15-25 degrees C) 2. Proper needle size 3. Proper needle management 4. Proper gun management 5. Proper injection placement 6. Proper pig handling 19

Vaccination Technique 7. Proper attention post vaccination 8. Pigs undergoing the stress of vaccination need more air to breathe and to keep cool 9. Proper management of swellings 10.Due to the level of immune response, a transient rise in body temperature may occur for up to 2 days post vaccination 11.Minimise other interventions at time of vaccination e.g. tattooing, tagging 12. Ideally vaccinate 2-3 days before weaning 20

Porcilis PCV Do your clients sell at heavy market weights? Is circovirus impacting on growth in the finisher phase? Do your clients have sporadic disease outbreaks in the finisher phase which are unexpected/unexplained? 21

The Future of Vaccines Combination Vaccines Intradermal Vaccination 22

Porcilis PCV M Hyo* Ready-to-Use protection against PCV and Mycoplasma hyopneumoniae 23

Porcilis PCV M Hyo Antigens: Adjuvant: Schedule: M. hyopneumoniae: strain J PCV2: ORF 2 antigen Emunade 1 dose (2 ml) from 3 weeks of age Onset of Immunity: PCV2: 2 wks M. hyopneumoniae: 4 wks Duration of Immunity: PCV2: 22 wks M. hyopneumoniae: 21 wks 24

Porcilis PCV M Hyo Claims: Reduction of M. hyopneumoniae lesions Reduction of PCV2 viremia/shedding/virus load in lungs and lymphoid tissue Reduction of loss of daily weight gain during the finishing period in face of M. hyopneumoniae and/or PCV infections 25

IDAL Device - needle free intradermal delivery of vaccines IDAL device is currently being assessed by APVMA 26

What does needle free mean for the pig? Without needle Less stress & pain Vaccination abscess following intramuscular injection Improved welfare No tissue damage Reduced transmission of diseases 27

28 University of Veterinary Medicine Gießen, Germany in Cooperation with MSD Animal Health, Germany

QUESTIONS? AU/OSW/0917/0006 29